0001575872-22-000068.txt : 20220207 0001575872-22-000068.hdr.sgml : 20220207 20220207062341 ACCESSION NUMBER: 0001575872-22-000068 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20220207 FILED AS OF DATE: 20220207 DATE AS OF CHANGE: 20220207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DR REDDYS LABORATORIES LTD CENTRAL INDEX KEY: 0001135951 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15182 FILM NUMBER: 22595444 BUSINESS ADDRESS: STREET 1: 8-2-337, ROAD NO.3 BANJARA HILLS CITY: HYDERABAD STATE: K7 ZIP: 500-034 BUSINESS PHONE: 91 40 49002900 MAIL ADDRESS: STREET 1: 8-2-337, ROAD NO.3 BANJARA HILLS CITY: HYDERABAD STATE: K7 ZIP: 500-034 6-K 1 drr0365_6k.htm FORM 6-K

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

February, 2022

 

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x Form 40-F   ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes  ¨ No   x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

 

 

 

 

 

 

EXHIBITS

 

Exhibit
Number

  Description of Exhibits
   
99.1   Press Release dated February 7, 2022

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DR. REDDY’S LABORATORIES LIMITED
(Registrant)
     
Date: February 7, 2022 By: /s/ Vivek Mittal
    Name: Vivek Mittal
    Title: Global General Counsel and Compliance Officer

 

 

EX-99.1 2 drr0365_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

February 7, 2022

 

Corporate Relationship Department National Stock Exchange of India Ltd.
BSE Limited “Exchange Plaza”
Dalal Street, Fort Bandra-Kurla Complex, Bandra (East),
Mumbai – 400 001 Mumbai – 400 051
Fax Nos.: 022-22723121 / 22723719 / Fax Nos.: 022-26598120/ 26598237/
                 22722037 / 22722039                  26598238
   
Scrip Code: 500124 Scrip Code: DRREDDY-EQ

 

Dear Sirs,

 

Sub: Press Release

 

Please find enclosed a Press Release on “Dr. Reddy’s Laboratories announces DCGI approval to the single-shot Sputnik Light vaccine in India”

 

This is for your information.

 

With regards,

 

/s/ Vivek Mittal  
Vivek Mittal  
Global General Counsel and Compliance Officer  

 

Encl: As above

 

CC:- New York Stock Exchange Inc.(Stock Code :RDY)

         NSE IFSC Ltd.

 

 

 

 

 

  CONTACT
DR. REDDY'S LABORATORIES LTD. Investor relationS Media relationS
8-2-337, Road No. 3, Banjara Hills,  
Hyderabad - 500034. Telangana, India.

AMIT AGARWAL

amita@drreddys.com

USHA IYER

ushaiyer@drreddys.com

 

Dr. Reddy’s Laboratories announces DCGI approval to the single-shot Sputnik Light vaccine in India

 

·Sputnik Light is the latest vaccine to be approved in India as part of the national inoculation effort in the fight against COVID-19

 

·Sputnik Light becomes the second COVID-19 vaccine to be made available in India by Dr. Reddy’s

 

Hyderabad, India, February 7, 2022 - Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy's”) today announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.

 

Sputnik Light is a one-dose vaccine and the same as the first component—recombinant human adenovirus serotype number 26 (rAd26)—of the two-dose Sputnik V vaccine. Following its Phase III clinical trial of the single-shot Sputnik Light vaccine in India, Dr. Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in Russia.

 

The standalone Sputnik Light vaccine is the latest vaccine to be approved by the DCGI as part of India’s national inoculation effort against COVID-19. Sputnik Light is the second COVID-19 vaccine to be made available in India by Dr. Reddy’s, reaffirming the company’s commitment to explore every avenue in the fight against the pandemic.

 

Sputnik Light has been approved in over 30 countries around the world including Argentina, UAE, Philippines and Russia. Earlier this year, an independent comparative study conducted by the Spallanzani Institute in Italy showed that Sputnik V demonstrates strong protection against the Omicron variant, with over two times higher virus neutralising activity compared to the Pfizer vaccine1. The data supports the results of the recent laboratory study by the Gamaleya Center demonstrating that Sputnik V induces robust neutralising antibody response to the Omicron variant, further strengthened by Sputnik Light as a booster2.

 

In September 2020, Dr. Reddy’s partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and distribute the vaccine in India. In April 2021, the DCGI granted approval to the two-dose Sputnik V vaccine for restricted use in emergency situation in India.

 

 

About Dr. Reddy's: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy's operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com

 

 

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults, currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers', products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the "Risk Factors" and "Forward-Looking Statements" sections of our Annual Report on Form 20-F for the year ended March 31, 2021. The company assumes no obligation to update any information contained herein.

 

 

 

 

1 Retention of Neutralizing response against SARS-CoV-2 Omicron variant in Sputnik V vaccinated individuals: https://www.medrxiv.org/content/10.1101/2022.01.15.22269335v1

2 Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant: https://www.medrxiv.org/content/10.1101/2021.12.17.21267976v1

 

 

 

GRAPHIC 3 drr0365_ex99-1img1.jpg GRAPHIC begin 644 drr0365_ex99-1img1.jpg M_]C_X0 817AI9@ 24DJ @ /_L !%$=6-K>0 ! 0 !D M #_X0.;:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B \ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835 @0V]R92 W+C$M8S P," W.2YD86)A8V)B+" R,#(Q+S T+S$T M+3 P.C,Y.C0T(" @(" @(" B/B \"UN&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N M861O8F4N8V]M+WAA<"\Q+C O&UP34TZ26YS=&%N M8V5)1#TB>&UP+FEI9#HW-3DW.$)!,#@T130Q,45#0C,Q,D-&1C5!,C(U-31! M,B(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#HW-3DW.$)!,3@T130Q,45# M0C,Q,D-&1C5!,C(U-31!,B(^(#QD8SIC#IX M;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^T 2%!H;W1OQ4G*",Q$ @$# P($!0(#!@4% 0(# !$$(1(% M,4%1(A,&87$R0A2!4J$C%9%B4[,D!\%R@C-#X;(T5#7_V@ , P$ A$#$0 _ M +^&E*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2O2:[M-/;';LNY,L4[(KJ.'DG)WBQKN%553"+%&HLJ@#Y5E6SOQM^6K,_4W(L+4\HVBT94P!:))A%6" LDR] MG)JD"\H2,HNX=I%9>Z N6)E/861+]@$.4!U#R\&.=2R +*/X_.O"*V M:_Y'.?+G(X\4,8JJ M0LR55VBFM79-JF/MR<5-D-\=9NH4Q3E/N 8"B%O+&DJ%)!=2*R^=71G<.F39T^) M"HF$X^I=<]AX?Y18DV1:Q O4R^B7;)CW6ZVT[/;2J.:2YG'1RW,ITCF*4X ;B8-P'4?)@./,8B;VH1:I@ZT5Y4$N]O?O& M/06H4JX9,K-PL[2]3SVOQ+2H-8]PND[8,OGKJ/3/Y!B5% 41 "B7F(F_36J* M43A'8@C4$7!&HK''R(,J(38[!HR2/D1H00=01W! (KM.H];ZQ/G M7+L'@3#V1LS65A(RL#C:JRELE(V(!$9-\TBT?=4;,OD'30]]7Z%Y" :B9N8F M%$)7!;=(B #Q=@H_2YUJ;QV#)R68F%&0KO?4]!8$_P#"M$1?\DCK0X;W:ZL4A1^H[E=D#< _:(:Z'^D2@ZNMJA $BXK;WT^[M8*[N8^4OV&) MMZJ,:[3C;35)YH6-M-3DU4_=2:3#!-=RB*3E(!,@NBJHBJ4!V,!@,4,>1XG) MXY(YW*OB2WV.O0E;;E-]5=;BZGL002""8<&;'-.^*P*948!*G]IO9E/0J;$ M];@@@&I=:JZF4TI6,LS9:J6",5WK,-[&2"GX\KSVRV#\.S)(2IH]B4#*)Q[) M1=JFY=J"(%(4RB91$?4P!ZZC965%AQK)+/VJ;:=:Z+U;[.XT[?8=A,XXE)9$J7//Y:-9I6R*;PT MXD[AG0M'A'3!K(2:"9?=#<@E6/R*/Z?35UR/%Y/%F$9.T^O")4VF_E+.FN@L M=R-I_&JG&S(B_2B6P/)/\K':K'_;[$,/F_%3*Q-J1/2DQ$ MQY;7&H1$T5U!/E8Z0(Z8M9"303 '*(^V8JQ@,7U]/IJXY'C,GBY(X\G;NEB6 M1=IOY6Z7T&OB*JL?,ARI9H8[[X'"-<=RH<6\1M85)P/4 ']VJ^I=:_\ O#Y' ML%="E<;M,M1URFY/)<@X2BH^GQC1ZI'P\>L@C*SLBJ^>LD0;LS."@5),3JJC MOL !ZZV<9&>4YM.#ATF9%8L?I4.VQ+VU)+> T&OPJ1+BRQ<1)R^AA1]@7[G< M+O('8>4$W)ZV'Q$\(B4:3D3%S3 QSL9B.8RK(RA/;4,TD6J3QL91/<>!Q16+ MN&X[#Z:]GB;'F>![;T8J;=+@V-O[*B1N)$5P" P!L>NOC7)!]0_U#6JLZ_.- M\FYK";O]VL_NDRXS 96D2G^0(\P8!&100P$#<0!$(CV. !Z<==7AV_%3;TVU MD.E04U)KVO"Y$0;KB B @BJ(" [" @0P@("'J @.E*N.]S;KXX;YT_Z=84[D M9.F:GDU/!^'K%4)O'\:O.WBAHRN/H%FM.3A$VKQBG7Y--/\ JMW0**+ 3W$T MQ$O(.:XZ>3(Y27%PB"4)L#T!)J(UQZ9^.[QF1F+.VUYR]<>U$G+&8W#K]B)E_;<1"W^3:>S( M1=HEGC-@Y62KT$L9)<5%@!/Y!0(*2ABB4NSD,[D8^2;@%AV\F!>0$V$27MO8 M^!((4+VP:MK8'I]S\G'3GR/V M^CX[[W=QI>7HRM))/*M6SB/M"(MFR[V!D%DDA20C'QYE7/?0!A:-SV%[W0^!-P38$J-:JN0R9,)6RHT,F(HNP' M_< '4@=&MX"QZFYZ5;0P-A?%W7W$].Q/AF%;P6.JO&@2O-4':DB=RB^.9\K) MNI1GIL&N7R/6]=UR01.K$,"+$$&Q!'8@Z6K?%+'/$ ML\1#1.H92.A!%P1\"*R]K36=5G/\E=7;#G6I'_OR-;%-O_" 9EWV_P#?6CBA M?WKB7Z?A3?YV-5_";>U,TCK^7C_Y>34^U^B/6;L;T*Q=7[OB>FM94W7:F3,' M=8"$CX6WP-C+CV/>HR[6:8-D':XJ/0YKI+&42< (\RB([A9_[@O/A\[R67@N M8LC'GG9+?39&8[&7H5(%K'I>XL17,^Q)VDP,+'R )()V"N&UOO<@L#U#"]PP M-^QN-*T$^/ONKF[J[TB[JMZ8^BIUU@.V5%YC]"VM7L2"<>@^9 M*%9NS,/DE3*J4I53B.K'G52;V72U2, M/B\>'W=RV""WH1<>\X -KRQ9 @#'_F3Z@+7;6IW=&?([Y+.X&3,(.$L&0)< M-;82K9ERC6Z=*#%/RD%19^Z))OI0[6&4CVRJ0'30!7B?U,;[N(6,?#\;#,^1 MR3-%AR81;J M1VVQ$FY-R+&U;C/(^,/O9T?ZQ]?,CT#LUB]7(5OG[9(346U)CN#MA'\& MXAB,TXLTI+"4&(+."F+Q.8I"\N6_IKZ;[EQWY'C\>'"%YXHIE<;B@+.Y*>8> M ^X:K;36N3XV#(Q^8GS)'VX\AA*'ZMNQ+/Y?GK;H>]9S\.^3HCJY7.[?=?($ M-.43KB1.*C:O!E9K>]89]Q.2X9?2R9BFT+;R%P" MH(;ZMX(V;O3W7%AK6T!>2=TX$^JT18'=KO*];;>A6QW@;RH!OT-3]R7Y7\$T M'IC7NYD/'S-@@;XA^(HU(6,W8S3^^E]Q)W4Y54[!.:JK*4V!RY'%MB M,&UD7RA?AKMYB4C BY9,JB/ 2_T.>^Y3;_:.SE>!QBL7'YDQBY$RP31A@ 7] M*5)2-I-_,J&UC<=;$5.X?.,.5)G8*^MCQQS1R6-]OJ1/%JPT!4N"=+'II4IN M@W=&A='/#[3VV:^JV16^2NE[NH8*S+5I" MG0.68TEJ0A&6X''98N.RYO2Y M!GCE0, "^Q@UMI-[,!I8W'@:O>'S?1S?ZAA+ZV-!O60 WVAD9/J&@*EA>XMV MTKNW6GN7F3HYXB,!97Q9CFJY!AW>:/*/[S-HI-52<@4(Z# MH#A\!#N=V4@K"T:2Z"ASK%)R^&7W.(;ZJ_<^%)PO)P\9A$2MF,A M@9M 8F&]G:W^$H8. ;;U*@]*F^V1_64F?._E#"WC(VZV*VVA;]Y=R;+]G%^] M0+R!"V+R;=,<&]P>QU6J&'Z-A6V7;+5OK-=AWD_9\E8[JI$Q81M6EI 45Z\R MLSUH9%=)0QTCAN??TVU+Y1<3V)SV-[DI]"X4C(ED'HB1OV*2DFT@E M>H!O3BY/$W MUU)_!CQ7@D]PL6R52VX[MMPP&H:P:VZQL!6)3'R#-B<(Q'XBK?U/,V MVPVDBZWN"I.TDK?4FK/^#-S&S\-723(=,3&()!KX.6'$D MG+#M@.PNPU](G0EAU],Z$D?2=;6)-7V)CC.(QD9$R;';?0.>RWZ!C]M[ ]+W MM50@Y%$E%$E4U$5D5#I+(JD,FJBJF82*)*IG ITU$S@(&*( ("&PZ[!65U#H M04(N"-00>A!\*BLK(Q1P5<&Q!T(([$5DLF#LQ2&+'F9FN,[HIB!&6)6763P@ M'PTAI..ED6:48APB7"MKNE,Y2\! M#7&.F7D^LNZ%F9R,=&R2,CQ057X"<41 =A#8-DO)QS^^.2S90Z8_(KCO 9-! M:"(0M&#>VXE?5(&GG[F]:N'P)4]KK"&5LN#,FDFC6YVC(;GD"_ MRN1K6"3^=]![U:JW7KKO@'(DYF)GB:N8O)8'1FUFG&V3Y&W4.9/%*MIJP MPD! HJ6*IHN3I$6?,G3/F=),.0%<) !0Y&UT7O+(?BB4$GP1P\;7^E=[= M>^T5?!S.3]I MO=F553)7(!D^F&U>_MA\D)!*=P(I% QN1 $NPS>>!.8DF+$,Z)TA M +VW*P"AMY-[>FP.RUSL"6.MAAPOK(7CR-N&Z2R'^8"',=HQS2-N&9+D1OLTVM^.NV0QD:.+,'N-6(/[:D?V%\NG3K*7C+ M=X!AFEA/E> =T,F?'.)&-FC57#L".NXB\5AU#$_3<5K]D#^A80@Y#1HL2 M:&PU$C.C(I'PNP\D>%+K_ )$I;)_.Q^),R9%G;K#LDE'! MD*[*+O(L;!\=(#&6;Q;HQ07, #[:*AC#Z .I_N7(3C/=?!1-W8*_IE+G3<0#I7OM@?FX'.\7$;9G]2290.KJF+$K*!W90_J6[A-!>II M=@O+;T]R?XS'. X9"Q*99F(A+!!HQ+=>;+/&_VT8YL,<=9! M1+[SB< 'EJN]X<;D\OSHR\$[H'STR-YT,:BY(L==POZ8'0C705[[*/]$Q@ MF> /2@EC*KJ)=^X+\+-<.Q/1A\JESXN\#U3LGX=D,+VM)(T;?I#+D.1Z<@'& M+EAMDDM"S)/0=E8J6117*/U^S;]=;_\ <3!>>3#FQ++R*8&/)$Q[.@NH/]UM M4;^ZS#O5=[1S5X_G>0FF!;&.4$D7]T;01JX^=C=2>C 'M5=Z"QAVAN&5Z3XG MK%)M58*J=B7KY6%COCR+>'E7;8C*QV()MHDP?=>1@\_E@B#!Q)D8G[(5D]29".C,)494(Z[B!<,*F<]ZOM/'S\?"LTN=) M RV_\KLH&.1?Z=ZLC.#W1+VVZWE\B4['.$NI-PIX4&0N>,\T>/EPLG$P<*14R$O9V&C/9F+"D^:7JJN$(6Q13% B8B1ZD!Q 1 M3.01#U[%9>5X]\2%&3-AD WR 6V':3>2-KJP+ %;[MP;2L'BP>1DRQE0G&: M,'8#J)+E?*C"S(0&8D'Z=A%]15Y_H=D;)N7.G^ LD9C243R/;*$PDK(LLR_' M+R"@K.$6$LNRXD!!>7C$D7)P I0$RHB [:T>Z\/%P>;DQ\10D?IQ,4'1'> M)'D0=P%D9EVGZ;6[50<%/+D<>'F8N1+*JL>K(DKHC$][H =WW=>]2WUSA (L M=0:N*K)^7OP[(WQ*R=I.J5;2;W=%-S-91Q/#MR(M[[<&3J.IQR>ZCJ8OW#JG4>6X%]&ZQ-:9'MCV%C.OSWJ.I=GS;"*UF2F)"ANHQFFLV ME6LTWEE6PO%6Y9)JB2::%640$P;+%'?;U#7>E(.5SN.S,BTK8DB&%@= "6 . MFC "1]OANJ@$;\4N=^.#%/DQR+*#UOL"-H>A*HJM\!6]7SC9#R_#]>>B-,A) MBQP^'[9A>!>VE**<.V4/8+6SJE7"-BYQ=J9,CPB$8JHLDV5,)##N;B(AKG>1 M6/)_W+Y:/, (BEE:!3])O/()' Z%ELJWZJ#<=;U-]N@P>PL:7'TG)A21A]03 MT 56_4*S7OTN0 ;]*P3_ (^EZN:_:.X8,755G\,WC%MFF+K19=L$Q43R,.[B MB12IIZ@X=Q=2IPQ#I_F:I0JO 2I4U0$JJ1)"+BVSM-)0IA Q2G HA]0UPHR, M@1F(2/Z9ZC<;'YB^OZU=.B2,'D4,X-P2 ;'Q'@?E65M::RII2N%G:Y 6AD$= M9(*%L$>"I5P8SL4QF&8+$ 0*J#600<( H4!$ -QW#?6AX2S^H" XZ&VH^1[5 MD'9054D ]?C\ZX.%QQ0JVZ*]KM'I4"Y =_DPM4@HISR#^$P.&+%!4!*/[]96 MR-I3U&VGM6LJK&[ $_*NQ2,0QF&IV4NS8RC)8O!TQD&3=ZR=%^H%7:.B*H*E M VP[&*(;AOK!( KAFUL;_K_P^=;%9E-U)!MVTKU65OLWK<$TC_P[:'B&T/LH48AM%LFT68%M_= T>BB5F8JHC]P M"0>7ZZR:PMKKTZ=:+Y#N31KWN-#?Q^=>9A"1<4V^%$QT=%L0,.X_KKUR9!:0[A:VNNGAKV^%> !3N71KWN-#?QO M7$0U$IE<-)GKM2JT >:$1F30MEC MT^5[VIDLV8I3*.]6%C?N/ U+=2$BU6!XE1@P4B5&(1:D4=DV/&'C02%#\>9@ M9,6@LA0'A[7#AQ]-MM1Y@,G=^1Y]_P!6[6]^YOU->0_Z;;^/Y-GT[=+6\+=* MB0R\=W1R.M,M=&?5S#J5CFT'3>2>_P!HL5$5TWQ3D>B1@H4T>@H[*<0.=-(I MA_:&M\>1-%C-B1NPQVM<7[ @@7Z@7 -@>M92NT\RY$IO,AN#\2"+GQ-B1KVJ M1%-Q)C3'=-2QY0Z-5ZE1T"OB(U*%AVC6O%))G.I(IFBBD%HH1\=0PJ@8H@?? MU#7F5-+G*$S&,J*@0!M0%!)"B_8$D_,FM<*+C2--CC9*S[R5T):P&XD=[ "_ M@!4;6?CHZ1Q]KE;JSZO8=)8IM!RWDG@U%J=!8CW?Y@D8*&,R05= /WF(F41# M]FO8\B>'&;$C9ACM8$7[#M?J!<7M?K6R5WGG7)E-YD-P?CTN;:$V-M:R/:Z( M&"NO5^@NL&+81M-0%/M+['&-*HVC8"+?6]X@X=,T6Z;E=I'('>2J@**"=0@' M'?UW'4#G,GD\K#(B9WRBJ1*Q-S&A8(6%^T2$N%[[;"I/#X_')R*ME[4Q6%44!5W H"&_829/'<5[:CX/BF!>3:)-M_+ M#&!LC)(%R[_S'ZVV+0;+YGW$>1S!;&AW,M^C3/IN4#HL27501:[74> M458G,4ITQ24*4Z9B&(YK!$2-0B *@ M%@!H / #PKRZQK*GTTZZ'I2JYGE1\+09^FW.?.IL7!0.5Y)XFM?\>.'+>"KM MW.HH J6.(<&(#*)LI1]7!#<$78?<(E4]39<)/-PN?%&OGX9I02O>$[@2R>,9 M[I]IU72ZU:9.5#R6"Z99V\DD1"2=I!:P23^\!]#ZW'E;LPD_4\==C\PY@A.J M/:_J=CFW=):1A''R$)GRRUCY;::TQ;(XO$XO!XQ MBV/+AJN8#T5U712.GE95"VO>Y-_#8E@[JGUQZU$ERX(PY1\8J3_M!-.ZS$)- M7\F1 3"BD[?J"J[402$WVI\P( ^NV^H4O(9D\ Q99&..&W;>U_$CN?B>G:O/ MQX?7_)*@S[;;CU \!X#QMUJ06H=;J:4II2FE*:4II2FE*:4II2FE*:4II2FE M*:4II2O@2E,&Q@ 0_>&^E*^"E*7^$H%W]1V _Z:4K[:4II2FE*:4II2FE*? MNTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI3 22E-*4TI32E-*4TI32E-*5__9 end GRAPHIC 4 drr0365_ex99-1img2.jpg GRAPHIC begin 644 drr0365_ex99-1img2.jpg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end GRAPHIC 5 drr0365_ex99-1img3.jpg GRAPHIC begin 644 drr0365_ex99-1img3.jpg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end